Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Facciabene

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Cancer Immunology, Immunotherapy : CII|August 13, 2015
Targeting tumor vasculature: expanding the potential of DNA cancer vaccinesStefano Ugel, John G Facciponte, Francesco De Sanctis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Endothelin B receptor, a new target in cancer immune therapyLana E Kandalaft, Andrea Facciabene, Ron J Buckanovich, et al.
Frontiers in Oncology|November 12, 2025
An early-stage 3D fibroblast-featured tumor model mimics the gene expression of the naïve tumor microenvironment, including genes involved in cancer progression and drug resistanceFrancesca Costabile, Subin George, Andrea Facciabene, et al.
Vaccine|December 7, 2007
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effectsAndrea Facciabene, Luigi Aurisicchio, Leonardo Elia, et al.
Human Gene Therapy|January 18, 2006
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protectionAndrea Facciabene, Luigi Aurisicchio, Leonardo Elia, et al.
Oncogene|April 27, 2020
Combination of CHEK1/2 inhibition and ionizing radiation results in abscopal tumor response through increased micronuclei formationHann-Hsiang Chao, Ilias V Karagounis, Christoforos Thomas, et al.
International Journal of Cancer|May 21, 2005
Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNACarmela Mennuni, Francesco Calvaruso, Andrea Facciabene, et al.
Journal of Applied Clinical Medical Physics|June 1, 2026
Three-Discipline Collaborative Radiation Therapy (3DCRT) debate: Medical physics should focus less on geometric precision and more on biological outcomesFrançois de Kermenguy, Susannah G Ellsworth, Andrea Facciabene, et al.
Gynecologic Oncology|December 5, 2009
The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decadeLana E Kandalaft, Nathan Singh, John B Liao, et al.
BMJ Oncology|May 13, 2025
Combined immune checkpoint inhibitors and ablative radiotherapy in metastatic cancers: a meta-analysis of prospective clinical trialsEduardo Urias, Jaehoon Lee, Christopher R Weil, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|August 13, 2015
Targeting tumor vasculature: expanding the potential of DNA cancer vaccinesStefano Ugel, John G Facciponte, Francesco De Sanctis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Endothelin B receptor, a new target in cancer immune therapyLana E Kandalaft, Andrea Facciabene, Ron J Buckanovich, et al.
Frontiers in Oncology|November 12, 2025
An early-stage 3D fibroblast-featured tumor model mimics the gene expression of the naïve tumor microenvironment, including genes involved in cancer progression and drug resistanceFrancesca Costabile, Subin George, Andrea Facciabene, et al.
Vaccine|December 7, 2007
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effectsAndrea Facciabene, Luigi Aurisicchio, Leonardo Elia, et al.
Human Gene Therapy|January 18, 2006
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protectionAndrea Facciabene, Luigi Aurisicchio, Leonardo Elia, et al.
Oncogene|April 27, 2020
Combination of CHEK1/2 inhibition and ionizing radiation results in abscopal tumor response through increased micronuclei formationHann-Hsiang Chao, Ilias V Karagounis, Christoforos Thomas, et al.
International Journal of Cancer|May 21, 2005
Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNACarmela Mennuni, Francesco Calvaruso, Andrea Facciabene, et al.
Journal of Applied Clinical Medical Physics|June 1, 2026
Three-Discipline Collaborative Radiation Therapy (3DCRT) debate: Medical physics should focus less on geometric precision and more on biological outcomesFrançois de Kermenguy, Susannah G Ellsworth, Andrea Facciabene, et al.
Gynecologic Oncology|December 5, 2009
The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decadeLana E Kandalaft, Nathan Singh, John B Liao, et al.
BMJ Oncology|May 13, 2025
Combined immune checkpoint inhibitors and ablative radiotherapy in metastatic cancers: a meta-analysis of prospective clinical trialsEduardo Urias, Jaehoon Lee, Christopher R Weil, et al.
Pageof 5